Rethinking Traditional Manufacturing Processes To Identify Green Opportunities
By Geert Schelkens, R&D Manager, Early Phase API
Developing greener, more sustainable processes across the pharmaceutical fine chemicals industry is critical and top of mind for drug developers and manufacturers alike. The complexities of these manufacturing processes produce a significant amount of waste by way of consumption, workup, and crystallization. As a result, the carbon footprint and waste-to-product ratio in the pharmaceutical fine chemical industry is among the highest in the chemical industry. To combat this, developers will need to enlist a broad array of renewable, raw material sources, green chemistry strategies, and innovative technologies. The key is identifying how best to break bad manufacturing habits, developing strategies for sustainable active pharmaceutical ingredient production, and designing approaches to reach sustainability targets.
Beyond responsibility to the community and environment, sustainability is a strategic choice and differentiator in the pharmaceutical fine chemicals field. To ensure green processes throughout your workflow, it is important to prioritize carbon neutral manufacturing, green supply chains, and an overarching sustainability strategy. To learn more about what this looks like in practice, download the full article.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.